Ina Valeria Zurlo

Codon-specific KRAS mutations predict survival benefit of trifluridine/tipiracil in metastatic colorectal cancer

Joris van de Haar, Xuhui Ma, Salo Ooft et al. · Nature Medicine · 2023 · 84 citations · Full text

Medicine, Oncology, Pharmacology +17

Predictive value of NLR, TILs (CD4+/CD8+) and PD-L1 expression for prognosis and response to preoperative chemotherapy in gastric cancer

Ina Valeria Zurlo, Mattia Schino, Antonia Strippoli et al. · Cancer Immunology Immunotherapy · 2021 · 79 citations · Full text

Medicine, Oncology, Surgery +17

Mutational status of plasma exosomal KRAS predicts outcome in patients with metastatic colorectal cancer

Donatella Lucchetti, Ina Valeria Zurlo, Filomena Colella et al. · Scientific Reports · 2021 · 38 citations · Full text

Medicine, Molecular Biology, Oncology +17

Treatment of Locally Advanced Gastric Cancer (LAGC): Back to Lauren’s Classification in Pan–Cancer Analysis Era?

Ina Valeria Zurlo, Michele A. Basso, Antonia Strippoli et al. · Cancers · 2020 · 24 citations · Full text

Medicine, Oncology, Surgery +16

Evaluation of Second-Line Anti-VEGF after First-Line Anti-EGFR Based Therapy in RAS Wild-Type Metastatic Colorectal Cancer: The Multicenter “SLAVE” Study

Alessandro Parisi, Alessio Cortellini, Katia Cannita et al. · Cancers · 2020 · 21 citations · Full text

Medicine, Oncology, Pharmacology +17